Harte-Hanks, Inc. (HHS) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $2.51 --0%
Financial Fact:
Advertising, selling, general and administrative: 11.59M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Advertising, selling, general and administrative: 11.59M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Harte-Hanks, Inc. (NYSE: HHS) reported Q3 EPS of $0.19, $0.01 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $212.79 million versus the consensus estimate of $213.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
